Vitamin D deficiency and co-morbidities in COVID-19 patients - A fatal relationship?
作者信息
Biesalski Hans K
机构信息
Institute of Nutritional Sciences, University Hohenheim, D 70599 Stuttgart, Germany.
出版信息
NFS J. 2020 Aug;20:10-21. doi: 10.1016/j.nfs.2020.06.001. Epub 2020 Jun 7.
Abstract
摘要
相似文献
1
Vitamin D deficiency and co-morbidities in COVID-19 patients - A fatal relationship?
NFS J. 2020 Aug;20:10-21. doi: 10.1016/j.nfs.2020.06.001. Epub 2020 Jun 7.
2
Corrigendum to "Vitamin D deficiency and co-morbidities in COVID-19 patients - A fatal relationship?" [NFS Journal 20 (2020) 10-21].
NFS J. 2020 Nov;21:38. doi: 10.1016/j.nfs.2020.09.001. Epub 2020 Sep 9.
3
Increased risk for COVID-19 in patients with vitamin D deficiency.
Nutrition. 2021 Apr;84:111106. doi: 10.1016/j.nut.2020.111106. Epub 2020 Dec 4.
4
Low 25(OH)D Level Is Associated with Severe Course and Poor Prognosis in COVID-19.
Nutrients. 2021 Aug 29;13(9):3021. doi: 10.3390/nu13093021.
5
High-dose vitamin D substitution in patients with COVID-19: study protocol for a randomized, double-blind, placebo-controlled, multi-center study-VitCov Trial.
Trials. 2022 Feb 4;23(1):114. doi: 10.1186/s13063-022-06016-2.
6
The relationship between 25(OH) vitamin D levels and COVID-19 onset and disease course in Spanish patients.
J Steroid Biochem Mol Biol. 2021 Sep;212:105928. doi: 10.1016/j.jsbmb.2021.105928. Epub 2021 Jun 6.
7
25 Hydroxyvitamin D Serum Concentration and COVID-19 Severity and Outcome-A Retrospective Survey in a Romanian Hospital.
Nutrients. 2023 Feb 28;15(5):1227. doi: 10.3390/nu15051227.
8
The effect of vitamin D deficiency on platelet parameters in patients with COVID-19.
Front Cell Infect Microbiol. 2024 Mar 8;14:1360075. doi: 10.3389/fcimb.2024.1360075. eCollection 2024.
9
Can Vitamin D and L-Cysteine Co-Supplementation Reduce 25(OH)-Vitamin D Deficiency and the Mortality Associated with COVID-19 in African Americans?
J Am Coll Nutr. 2020 Nov-Dec;39(8):694-699. doi: 10.1080/07315724.2020.1789518. Epub 2020 Jul 13.
10
Cholecalciferol level and its impact on COVID-19 patients.
Egypt J Intern Med. 2022;34(1):23. doi: 10.1186/s43162-022-00116-w. Epub 2022 Feb 21.
本文引用的文献
1
Avoidance of vitamin D deficiency to slow the COVID-19 pandemic.
BMJ Nutr Prev Health. 2020 May 20;3(1):67-73. doi: 10.1136/bmjnph-2020-000096. eCollection 2020.
2
Retraction Note to: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion.
Cell Mol Immunol. 2020 Aug;17(8):894. doi: 10.1038/s41423-020-0498-4.
3
Vitamin D and Inflammation: Potential Implications for Severity of Covid-19.
Ir Med J. 2020 May 7;113(5):81.
4
Temperature, Humidity, and Latitude Analysis to Estimate Potential Spread and Seasonality of Coronavirus Disease 2019 (COVID-19).
JAMA Netw Open. 2020 Jun 1;3(6):e2011834. doi: 10.1001/jamanetworkopen.2020.11834.
5
Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study.
BMJ. 2020 Jun 3;369:m2094. doi: 10.1136/bmj.m2094.
6
Hospitalization and Mortality among Black Patients and White Patients with Covid-19.
N Engl J Med. 2020 Jun 25;382(26):2534-2543. doi: 10.1056/NEJMsa2011686. Epub 2020 May 27.
7
The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system.
Cytokine Growth Factor Rev. 2020 Jun;53:25-32. doi: 10.1016/j.cytogfr.2020.05.003. Epub 2020 May 11.
8
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study.
Lancet. 2020 Jun 6;395(10239):1771-1778. doi: 10.1016/S0140-6736(20)31103-X. Epub 2020 May 13.
9
Kawasaki-like disease: emerging complication during the COVID-19 pandemic.
Lancet. 2020 Jun 6;395(10239):1741-1743. doi: 10.1016/S0140-6736(20)31129-6. Epub 2020 May 13.
10
Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China.
Diabetes Care. 2020 Jul;43(7):1392-1398. doi: 10.2337/dc20-0576. Epub 2020 May 14.
Zotero 插件